共 50 条
- [41] Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO EUROPEAN JOURNAL OF CANCER, 2015, 51 : S728 - S728
- [45] Chemoradiotherapy using low-dose protracted infusion of 5-FU alone is as effective as 5-FU combined with cisplatin for Advanced esophageal cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S290 - S290
- [46] Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
- [48] Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1120 - 1128
- [50] COMBINATION CHEMOTHERAPY OF CISPLATIN AND 5-FU IN ADVANCED COLORECTAL-CARCINOMA CANCER TREATMENT REPORTS, 1986, 70 (04): : 465 - 468